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Purpose: The crystalline lens is a unique cellular organ that performs metabolic processes while maintaining transparency
for optical functionality. Mitochondria play a role in providing cells with aerobic respiration necessary for these metabolic
processes. Using menadione, a mitochondria-specific inhibitor of the quinone family, and bovine lenses in vitro, this study
was undertaken to determine whether a relationship exists between mitochondrial function and optical function.
Methods: Bovine lenses were treated with 50 μM, 200 μM, 600 μM, and 1,000 μM menadione and lens optical function,
assessed as optical quality, was observed over 9 days. Confocal micrographs of mitochondria in superficial secondary
fiber cells were also analyzed in 50 μM, 200 μM, and 600 μM menadione-treated lenses over 48 h.
Results: A decrease in lens optical quality was observed in a dose-dependent manner within 24 h for the 200 µM-
(p=0.0422), 600 µM- (p<0.0001), and 1,000 μM- (p<0.0001) treated lenses. No change in optical quality was observed
for the 50 μM-treated lenses. Analysis of confocal micrographs indicated a trend of shorter mitochondria for 200 μM- and
600 µM-treated lenses with time and analysis of the distributions of mitochondrial lengths indicated a relative increase in
the number of shorter mitochondria with higher doses of, and longer exposures to, menadione.
Conclusions: The data show that menadione has a detrimental effect on mitochondrial integrity and this change is
associated with degradation of optical quality, suggesting a possible link between mitochondrial function and optical
function.
As a living and constantly growing cellular organ, the
crystalline  lens  must  carry  out  the  usual  ATP-essential
metabolic processes required for maintenance and growth,
while  also  ensuring  transparency  to  allow  for  the  proper
optical functionality of fine focusing light onto the retina.
While originally thought to be absent from superficial fiber
cells of crystalline lenses, and few in number within lens
epithelial cells, mitochondria have recently been shown to be
more numerous [1] and more dynamically active [2] in both
cell types than was previously thought. These new findings
suggest that mitochondria may contribute more to overall lens
metabolism than was once believed.
Within the bovine crystalline lens, mitochondria account
for approximately 33% of all ATP produced through oxidative
phosphorylation, while the remaining ATP present results
from glycolysis [3]. Despite the need for ATP production,
mitochondria pose a potential problem to transparency, since
in a structure as thick as the lens, mitochondria could scatter
light [4]. To maintain lens transparency, a part of secondary
lens  fiber  differentiation  includes  the  degradation  of
mitochondria (as well as other membrane bound organelles)
within and in areas just adjacent to the lens nucleus [5], called
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the organelle-free zone. Thus, mitochondria in the lens are
localized to the anterior epithelium and to the most superficial
fiber cells. The activity of the remaining mitochondria appears
to  be  important  for  normal  functioning  of  the  lens,  as
disruption of the natural organelle degradation process during
development by premature inactivation of the mitochondrial
oxidative phosphorylation of superficial mitochondria causes
the  organelle-free  zone  to  develop  opacities,  known  as
cataracts [6,7]. Given these findings, the mitochondria of the
superficial cortex must play a great role in lens metabolism
and possibly cataract formation, even though they occupy
only a minute portion of the lens.
The purpose of this study was to evaluate the relationship
between mitochondrial function (assessed by mitochondrial
integrity) and optical function of the bovine crystalline lens
using the mitochondrial uncoupler menodione at different
concentrations  to  understand  mechanisms  of  toxicity  and
possible recovery from this model chemical. Menadione (2-
methyl-1,4-naphthoquinone), also known as vitamin K3, is a
member of the quinone family and is known to have both toxic
[8] and non-toxic effects [9]. Toxic effects occur principally
by a one-electron reduction in mitochondria. At high levels,
menadione is detrimental to cells [10,11], however, at low
levels, menadione has been shown to be non-toxic and may
even improve mitochondrial function [12]. This study was
undertaken to examine how the integrity of the mitochondria
affects lens transparency. As no studies to date have been
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270performed on cultured bovine lenses using menadione, the
effectiveness of menadione as a bovine lens mitochondrial
uncoupler was also verified.
METHODS
Eye dissection: Whole bovine eyes were obtained from a local
abattoir (Cargill Meat Solutions Ltd., Guelph, ON, Canada).
Using aseptic techniques, eyes were dissected and lenses were
carefully excised, then immediately placed on a plastic ring
suspended in a glass chamber containing 23 ml of culture
medium M199. Culture medium consisted of M199 (M3769;
Sigma,  St.  Louis,  MO)  modified  with  26.2  mM  sodium
bicarbonate,  25.0  mM  4-(2-Hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES), 0.68 mM L-glutamine, 0.7%
sodium  hydroxide,  1%  penicillin/streptomycin,  and  3%
qualified fetal bovine serum. During the study, lenses were
incubated at 37 °C with 5% CO2 and replaced with fresh
culture medium every 48 h. Following 24 h of incubation
lenses were visually inspected and those showing signs of
mechanical damage were discarded.
Lens treatment: Using aseptic techniques, the lenses were
exposed  for  30  min  to  culture  medium  containing  0  μM
(control, n=10), 50 μM (n=9), 200 μM (n=9), 600 μM (n=8),
and  1,000  μM  (n=9)  of  menadione  salt  (M2518;  Sigma,
Oakville,  ON)  dissolved  in  culture  medium  at  room
temperature. Lenses were then washed three times with 0.9%
saline solution, once in serum-free M199 and then returned to
their chambers containing fresh M199. Lenses used as control
(n=10) were treated with medium and washed in the same
manner.
Assessment  of  optical  function:  Lens  optical  quality  and
sharpness of focus were assessed using the Scantox™ In vitro
Lens  Assay  System  (XTOX  Scientific,  Napean,  ON)  [1],
which  captures  images  of  refracted  laser  beams  passing
through the lens at various eccentricities from the optical axis.
The distance between the most posterior point of the lens (the
back vertex of the lens) and the point at which the refracted
beam crosses the optical axis (focal point) is the back vertex
distance (BVD). In this study, lenses were optically scanned
before treatment, then again at 4, 24, 48, 144, and 216 h post
treatment, using 22 laser beams per lens at each time point.
BVD variability, calculated as standard error, was used as an
indicator  of  optical  quality,  with  greater  BVD  variability
indicating  worse  optics.  Only  lenses  with  pre-treatment
(baseline)  BVD  variability  values  between  0.200  and
0.400 mm were included in this study.
Assessment of secondary fiber cell mitochondrial integrity:
For mitochondrial integrity analysis, lenses were carefully
removed  from  their  chambers  and  incubated  in  20  µM
Rhodamine 123 (R-302; Molecular Probes, Eugene, OR) in
serum-free M199 for 20 min at 37 °C. The lenses were then
rinsed in serum-free medium. Each lens was placed on its
equatorial region and immobilised on a Corning No. 1 (VWR,
Mississauga, ON) cover glass glued to the bottom of a well
(6-well  plate)  using  1%  (w/v)  agarose.  The  agarose  was
previously melted in M199 and cooled to 35 °C.
Mitochondrial  integrity  in  secondary  fiber  cells  was
assessed using a Zeiss confocal laser scanning microscope
(CLSM;  Carl  Zeiss,  Toronto,  ON)  510  META  system
connected  to  an  Axiovert  200  inverted  microscope  (Carl
Zeiss) equipped with a water immersion C-Apochromat (color
corrected)  40×  objective  (NA  1.2).  Rhodamine  123
fluorescence was visualized using an argon/krypton laser with
a 514 nm excitation laser line and a 560 nm long-pass emission
filter. Micrographs of secondary fiber cells residing in the
superficial cortex were taken for 0 µM (control), 50 µM,
200 µM, and 600 µM menadione-treated lenses at 4, 24, and
48 h post treatment. Since the Scantox™ results indicated that
most of the damage had occurred by 48 h, mitochondrial
integrity was assessed up to that time point. Similarly, the
results for the 1,000 µM lenses were not different from those
of the 600 µM lenses and therefore 1,000 µM lenses were not
assessed.
Mitochondria were counted and their average and total
lengths were measured in micrographs of secondary fiber cells
using  analysis  software  script  written  for  MATLAB
(Mathworks, Natick, MA). Micrographs from three areas per
lens were used in the analysis with three lenses per treatment
group per time point, for a total of 108 micrographs analyzed.
For each micrograph, analysis consisted of retracing each
individual mitochondrion using both an automated process
and the manual use of the fine adjustment tools of the analysis
software  to  ensure  that  mitochondria  information  was
correctly  calculated.  To  examine  how  the  distributions  of
mitochondrial lengths and numbers changed as a function of
exposure time to and concentration of menadione, frequency
histograms of mitochondrial lengths were generated for all
mitochondria  within  each  lens.  As  the  longest  observed
mitocondrion was 112.29 μm in length, histogram plots with
57 bins of 2 μm increments were used.
Statistical analysis: BVD variability data were normalized
using a log transformation to account for inhomogeneous
variance  between  the  dosage  groups.  Data  were  analyzed
using  a  two-way  repeated  measures  analysis  of  variance
(ANOVA)  with  Tukey  or  Bonferroni  post-hoc  tests.
Greenhouse-Geisser corrections were used for epsilon values
of  less  than  0.75.  Mitochondrial  lengths,  mitochondrial
numbers and mitochondrial distributions were analyzed using
two-way  ANOVA  tests  with  Tukey  post-hoc  tests  where
necessary. For all tests, results were considered significant at
p≤0.05.
RESULTS
Optical function: Treatment of bovine lenses with menadione
in vitro was associated with both a time-dependent (p<0.0001)
and a concentration-dependent (p<0.0001) increase in BVD
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271variability, indicating a decrease in optical quality (Figure 1).
Interactions were also noted between the two factors (time and
concentration;  p<0.0001).  No  changes  in  BVD  variability
were observed within the 0 μM- (control) and 50-μM treated
lenses over time (p=0.6200 and p=0.1130, respectively) but
for all other dosage groups, differences in BVD variability
changed as a function of time. BVD variability in the 200-
μM treated lenses showed increases relative to baseline (time
point 0) beginning at 4 h, but changes were not significant
until 24 h after treatment (p=0.0422). The increased BVD
variability for this group was maintained through the 48, 144,
and  216  h  time  points  (p=0.0002;  p<0.0001;  p=0.0025,
respectively). Lenses treated with 600 μM menadione also
showed significantly higher BVD variability at all time points
relative to the baseline beginning at 24 h (24, 48, 144, and 216
h; p<0.0015 for all time points). In addition, these lenses
showed two time points of peak BVD variability, the first,
smaller increase at 24 h (p<0.0001), and a second, larger
increase at 144 h (p<0.0001), with both BVD variabilities at
these two time points also significantly different (p=0.0424)
from each other. The decrease in BVD variability at 48 h
separating the two peak values was significantly different
from the second peak (144 h: p<0.0001) but not the first
(p=1.000).  The  1,000  µM-treated  lenses  responded  in  a
similar manner as those for the 600 µM group, with significant
increases at 24, 48, 144, and 216 h (p<0.0001 for all time
points) and apparent peak BVD variabilities at 24 and 144 h;
however, for this group, the second peak BVD variability at
144  h  was  not  different  from  the  earlier  peak  at  24  h
(p=1.0000) and the decrease between the peaks was also not
different  from  either  peak  value  (p=1.000  and  p=0.3076,
respectively).
As might be expected given the time course of differing
menadione doses, there were differences between the drug
effects at various time points (p<0.0001; Figure 1). No dosage
effects  were  detected  over  the  first  4  h  (p=0.6056),  but
beginning at 24 h, BVD variability for two highest dosage
groups were significantly different than those for the two
lowest dosage groups. Specifically, BVD variability in the
600 µM and 1,000 µM groups were greater than those for the
0  µM  group  (p=0.0030  and  p=0.0010,  respectively)  and
50 µM group (p=0.0013 and p=0.0005, respectively). The
BVD  variability  for  the  200  µM-treated  lenses  was
intermediate to the low and high dosage level groups and
showed no significant differences to any of the other groups
(0  µM:  p=0.5949;  50  µM:  p=0.3815;  600  µM:  0.1205;
1,000  µM:  p=0.0585).  At  48  h,  BVD  variability  of  the
1,000 µM was still significantly higher than those of the 0 µM
and 50 µM groups (p=0.0001 and p=0.0043, respectively) but
BVD variability for the 600 µM group was no longer different
from those of the two lowest dose groups (p=0.3941 and
p=0.8950). The second peak value (at 144 h) showed much
the  same  pattern  as  for  the  first,  with  the  600  µM-  and
1,000 µM-treated lenses showing significantly greater BVD
variabilities than those of the 0 µM- and 50 µM-treated lenses
(p<0.0001 for all comparisons). However, for this time point,
the BVD variability for the 200 µM-treated lenses was also
different from those for the 600 µM and 1,000 µM groups
(p=0.0026 and p=0.0300, respectively), but not different from
those  for  the  0  µM  and  50  µM  groups  (p=0.2051  and
p=0.2268, respectively). This pattern was mostly maintained
Figure 1. Effects of menadione on back
vertex distance variability. Line graphs
show the effects of 0 µM (control; black
circles), 50 μM (blue diamonds), 200
μM  (red  triangles),  600  µM  (orange
squares)  and  1,000  µM  (green
hexagons)  menadione  treatment  on
BVD  variability  (±standard  error).
Asterisks (*) denote significant changes
(p≤0.05)  in  BVD  variability  with
respect to its pre-treated scan (time 0).
Daggers (†) denote significant changes
in BVD variability with respect to the
control group (0 µM) at the given time
point. Results show an increase in BVD
variability as a function of menadione
concentration and time.
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200 µM-treated lenses showing similar BVD variability to
that of the 1,000 µM-treated lenses (p=0.0601).
Secondary fiber cell mitochondrial integrity: Mitochondrial
integrity was assessed using confocal images of lens fiber
cells,  with  shorter  mitochondrial  lengths  and/or  increased
numbers of mitochondria taken to indicate more damaged
mitochondria.  Visual  assessment  of  the  confocal  images
showed  that  in  general,  shorter  mitochondria  and  greater
numbers  of  mitochondria  were  associated  with  increasing
concentrations of, and exposure times to, menadione (Figure
2), indicating overall damage to the mitochondria. The sum
of the lengths (total length) of all mitochondria was taken to
represent the total amount of mitochondria (Table 1). No
changes as a function of time of exposure to (p=0.5837) nor
concentration of (p=0.1090) menadione was detected; nor was
any interaction detected between the two factors (p=0.3236),
which  suggests  no  changes  in  the  total  amount  of
mitochondrial  material.  However,  the  average  number  of
mitochondria  per  lens  did  increase,  both  as  a  function  of
concentration (p=0.0488) and of time (p=0.0263), and there
was  significant  interaction  between  the  two  factors
(p=0.0059;  Table  1).  Overall,  the  average  number  of
mitochondria  in  600  µM-treated  lenses  was  significantly
higher than that in the 0 µM-treated group (p=0.0456). The
greatest change in mitochondrial numbers occurred in the
200  µM  group;  mitochondrial  numbers  at  48  h  were
significantly greater than those at 4 h and 24 h (p=0.0027 and
p=0.0096,  respectively).  Also  at  48  h,  the  number  of
mitochondria for the 200 µM group was significantly greater
than those at the same time points for the 0 μM (p=0.0217)
and 50 μM (p=0.0306) groups. In contrast, analysis of the
number  of  mitochondria  per  micrograph  showed  no
differences at the 4 and 24 h time points (p>0.4415 for all time
points) for all dosage groups.
Despite  the  increase  in  mitochondrial  number  as  a
function of both dose of and exposure to menadione, statistical
tests could only verify an overall concentration-dependent
difference (p=0.0082) in mitochondrial lengths between the
50 μM and 600 μM groups (p=0.0087), with those of the
50 μM-treated lenses being longer (Table 1). No difference
over time (p=0.1417) nor any interaction between exposure
time and concentration factors could be detected (p=0.6472).
However, the trends for the mitochondrial lengths for the
200 µM and 600 µM groups to almost halve by 48 h suggested
that there were subtle changes to the lengths that could not be
analyzed with means alone. Relative frequency distribution
histograms were generated for each lens to characterize the
overall distribution of the mitochondria based on length. For
presentation purposes, histogram plots showing lengths only
up to 26 µm, comprising at least 95% of the total number of
mitochondria,  are  shown  (Figure  3).  All  histograms  were
skewed to the right, indicating a preponderance of shorter
mitochondria for all lenses. However, shifts in the distribution
to the left, indicating an increase in the number of smaller
mitochondria,  a  disappearance  of  larger  ones,  or  a
combination of the two, were observed as the concentration
of  menadione  or  exposure  time  to  menadione  increased
(compare Figure 3A to Figure 3L). This observation is also
borne out by assessments of the cumulative frequencies of the
histograms; in general, the proportion of mitochondria that are
shorter  than  8  µm  in  length  tends  to  increase  as  the
concentration and exposure time menadione increases (c.f.:
66% versus 94%).
Analysis of the relative frequency distribution histograms
indicated changes in the numbers of the smaller mitochondria
depending  on  post-treatment  time  and  concentration
(p<0.0001).  As  expected,  no  change  in  distribution  was
detected for the 0 μM or 50 μM treatment groups over time.
The  200  μM-treated  lenses  contained  more  short
mitochondria  for  the  48  h  (0–2  µm:  p=0.0002,  2–4  µm:
p=0.0002, 6–8 µm: p=0.0183) time point when compared with
the 4 h time point. Lenses treated with 600 µM menadione
showed  significantly  increased  numbers  of  shorter
mitochondria at both the 24 h (0–2 µm: p=0.0002) and 48 h
(2–4 µm: p=0.0002) time points compared to the 4 h time
point. When compared to the 0 µM-treated lenses, a relative
increase  in  shorter  mitochondria  was  observed  for  the
200  μM-  (2–4  µm:  p=0.0010)  and  600  μM-  (0–2  µm:
p=0.0002) treated lenses at the 24 h time point. A similar
increase in shorter mitochondria was found at the 48 h time
point for 200 μM- (0–2 µm and 2–4 µm: both p=0.0002) and
600 μM- (2–4 µm: p=0.0002) treated lenses compared to the
0 μM treatment group. In contrast, the 50-μM treated lenses
showed a decrease in relative distribution for the mitochondria
shorter than 2 µm in length (p=0.0074) at the 48 h time point
compared with the 0 μM treatment group, indicating a shift
toward a higher relative distribution of longer mitochondria.
DISCUSSION
We used a scanning laser monitor (ScanTox™) to assess how
menadione-induced changes to mitochondria might affect the
optical  quality  of  lenses  in  vitro  and  have  found  that
menadione has effects at lower concentrations and in shorter
exposure times than previously reported. Hedge and Varma
[13] reported cataractogenesis in rat lenses that were exposed
to 1,000 µM menadione for 5 h, while we found signficant
optical degradation in 200 µM-treated lenses by 24 h. The
increased sensitivity of a lenticular in vitro model used with
a scanning laser monitor suggests a more sensitive means of
objectively  determining  toxicity  effects.  Confocal
microscopy  provides  high  resolution  and  greater  contrast
images superior to conventional light microscopy, but without
the  artifacts  associated  with  electron  microscopy  [14,15].
Together with the scanning laser monitor, we have in our
possession a powerful means to record important toxicity
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273parameters previously difficult to measure using other in vitro
methods [16].
The results showing that the optical quality of lenses
exposed to increasing concentrations of menadione becomes
increasingly  degraded  (Figure  1)  indicates  an  association
Figure 2. Effects of menadione on mitochondrial integrity. Representative confocal micrographs of mitochondria in secondary fiber cells for
0 µM (A-C), 50 µM (D-F), 200 µM (G-I) and 600 µM (J-L) menadione-treated lenses at 4 h, 24 h, and 48 h. Scale bar represents 20 µm.
Note the increase in the number of smaller mitochondria as menadione concentration and time increase.
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274between optical quality and health of mitochondria within the
lens. The toxic effects of menadione on optical degradation
seem to be grouped in a linear manner, with 0 µM and 50 µM
treatments  producing  no  toxic  effects,  the  600  μM  and
1,000 µM treatments resulting in significant degradation and
the 200 µM treatments generating changes intermediate to the
lower and higher concentration treatment groups (Figure 1).
The  lack  of  optical  differences  between  600  μM-  and
1,000 μM-treated lenses were taken to indicate that a maximal
concentration, at which menadione effects were saturated, had
been reached. As a result, increasing concentrations beyond
this saturation point would have no additional detectable toxic
effects.
It  has  been  previously  demonstrated  that  the  optical
quality of a lens can recover from mild toxic exposure [1,17,
18]. The observations of decreases or “dips” in the BVD
variability between at 24 h and 48 h in lenses exposed to the
two highest concentrations (600 µM and 1,000 µM; Figure 1)
might suggest at least a partial recovery from menadione
effects, where the lens begins to overcome the initial toxic
insult before being overwhelmed by the toxin. This idea raises
the question of why the 200 µM-treated lenses showed no
recovery. However, examination of the 200 µM-treated lenses
indicates that recovery effects did occur in these lenses, albeit
not in all of them (data not shown); 5 out of the 9 lenses
showed recovery, leading to an overall difference in optical
quality compared to the 600 µM (p=0.0055) and 1,000 µM
(p=0.0488) treatment groups (data not shown). These findings
may suggest that there is a certain threshold of damage that
the  lens  will  tolerate  and  recover  from  before  being
overwhelmed.
While  the  first  decrease  in  BVD  variability  for  the
600 µM- and 1,000 µM-treated lenses might be acceptable as
a partial recovery point, it is highly unlikely that the second
decrease in BVD variability (at 216 h) observed for these
lenses  could  be  a  recovery  point.  First,  analysis  of  the
mitochondrial  integrity  suggests  that  the  mitochondrial
damage would be too great at this time point for recovery to
occur; by 48 h (the last time point for which confocal images
of  mitochondria  were  collected),  some  areas  of  600  µM-
treated lenses already contained no mitochondria, indicating
complete  mitochondrial  degradation  (data  not  shown).
Second, it was observed that as lenses became more damaged,
more beams were scattered beyond the range of the cameras,
resulting in fewer of the refracted laser beams captured by the
cameras (data not shown). As a result, those longer focal
lengths  that  would  have  contributed  to  a  higher  BVD
variability were not included in the calculation, resulting in
falsely  lower  values  for  BVD  variability.  Thus, the  more
damaged a lens becomes, after a certain point, the better the
BVD variability would appear, since the most scattered laser
beams would be excluded from the analysis. This calculation
artifact is a limit of the optical scanner; artificially lower BVD
variabilities can arise when lenses are extremely damaged so
that scatter is too great and the few “good” beams that can be
captured, are used for the variability calculations.
Given that no changes were detected in the total amount
of mitochondrial material, but that mitochondrial numbers
increased with increased exposure to and concentrations of
menadione (Table 1), changes in mitochondrial lengths were
also expected but were not evident with analysis of means
alone  (Table  1),  most  likely  a  result  of  low  power  (the
micrograph analysis is highly labor intenstive and analysis of
108 micrographs is equivalent to only n=3). However, the
distributions of the various-sized mitochondria indicate that
the effects on 200 μM-treated lenses again lie intermediate to
the those exposed to higher dosed lenses (600 µM) and lower
dosed (0 µM and 50 µM) lenses; at 4 h post-treatment, average
lengths are similar to those of 0 μM- and 50 μM-treated lenses
at the same time point, but by 48 h, average lengths resemble
those of the 600 μM-treated lenses. These data indicate that,
as with optical degradation in the lens, increasing doses of
menadione  were  generally  associated  with  a  linearly
increasing degradation of mitochondria. Moreover, the time
course for changes in optical quality and in mitochondrial
integrity both center around 24 h, suggesting an association
TABLE 1. AVERAGE LENGTH OF MITOCHONDRIA, THE NUMBER OF MITOCHONDRIA (COUNT), AND TOTAL LENGTH OF MITOCHONDRIA FROM CONFOCAL MICROSCOPY
MICROGRAPHS.
 
Average length±s.d. (µm) Number ±s.d. Total length±s.d. (µm)
Concentration
of menadione 4 h 24 h 48 h 4 h 24 h 48 h 4 h 24 h            48 h
0 µM 7.6±1.3 7.1±1.7 7.7±3.3 244±10 329±29 247±57 1848±275 2322±464     1814±788
50 µM 8.7±2.2 8.2±2.7 8.2±2.9 248±27 379±105 260±33 2205±799 3229±1610    2051±636
200 µM 7.9±0.8 6.4±2.6 3.7±0.9 165±57 214±73 607±190*† 1286±416 1414±767     2114±635
600 µM 5.9±1.0 5.1±2.6 3.6±0.6 380±36 431±286 447±52 2232±469 1730±781     1618±451
         Asterisk (*) denotes significant changes (p≤0.05) with respect to its 4 h time point. Dagger (†) denotes significant change with
         respect to 0 μM-treated lenses at the given time point. A trend toward a shorter average length and an increased number of
         mitochondria is observed.
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275between  mitochondria  integrity  and  morphology  with  the
optic functionality of the lens. The finding that mitochondria
in the 600 μM-treated lenses are generally shorter across all
time points compared to those for the other three treatment
groups  is  also  consistent  with  the  idea  that  fragmented
mitochondria in the lens is associated with a loss of optical
quality.
A link between increasing BVD variability and loss of
mitochondrial  integrity  has  been  previously  shown  by
Bantseev  et  al.  [1]  using  carbonyl  cyanide  m-
chlorophenylhydrazone (CCCP), a mitochondrial uncoupler
that is known to cause mitochondria to fragment [19,20]. That
mitochondrial integrity is adversely affected by menadione,
resulting  in  an  increase  in  the  number  of  smaller  sized
mitochondria, suggests that menadione too, might also act as
a mitochondrial uncoupler in the vertebrate lens. A recent
study by Makino et al. [21] showed that mitochondria in
diabetic  mouse  coronary  endothelial  cells  (MCEC)
fragmented in response to menadione exposure. Menadione
produces reactive oxygen species via reduction by complex I
of the respiratory chain at the inner matrix of the mitochondria
[9],  therefore  increased  mitochondrial  fragmentation  in
MCEC cells were thought to be the result of increased of
superoxide anion (O2
-); lowering of the O2
- levels with an
(O2
-)  inhibitor  led  to  restoration  of  normal  mitochondrial
morphology [21]. Mitochondrial fragmentation has also been
speculated to occur by free radical-induced solidification, or
hardening, of the normally fluid and free flowing lipoprotein
membrane  followed  by  the  shattering  of  the  membrane
resulting in fragmentation [22]. While this mechanism has
been  shown  to  exist  in  mitochondria  in  the  presence  of
hydoxyl radicals [22], it is unclear whether the mitochondria
in our experiment were fragmented in a similar manner.
Figure 3. Relative distributions of mitochondrial lengths. Histogram plots show the relative distributions of mitochondrial length for 0 µM
(A-C), 50 μM (D-F), 200 µM (G-I), and 600 µM (J-L) menadione-treated lenses at 4 h, 24 h, and 48 h. Only mitochondria less than 26 µm
in length, comprising a minimum of 95% of the total number of mitochondria, are shown. Percentages indicating the cumulative relative
frequency of mitochondria ≤8 µm in length are also shown on each graph. Asterisks (*) denote significant change over time within a given
concentration treatment group with respect to the 4 h time point. Daggers (†) denote a significant change in relative distribution for a given
mitochondrial size with respect to 0 µM-treated lenses. A general shift toward a greater relative frequency of smaller mitochondria as a function
of both time and concentration is observed.
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276Of  interest  was  the  finding  that  mitochondria  in  the
50 μM-treated lenses tended to contradict the general trend of
increasing damage with increasing levels of menadione. At
216 h, the optical quality of the 50 μM concentration group
was  significantly  better  than  that  of  the  1,000  μM  group
(p=0.0317,  Figure  1),  while  no  differences  were  detected
between the 0 µM and the 1,000 µM groups. Moreover, the
number of shorter mitochondria was greater in the 0 µM group
compared to the 50 µM group (Figure 3), an indication of less
damage to this latter group. The results suggest that low levels
of menadione may actually be beneficial to both the optical
quality of and mitochondrial integrity within the lens. The idea
that toxins can have a hormesis effect, i.e., that a toxin that
produces harmful effects at moderate and high doses can
produce a positive effect at low doses [23], is not entirely new
for mitochondria [24]. Previous findings by Shneyvays et al.
[12] show that low concentrations of menadione can benefit
mitochondria  that  have  a  defect  in  the  electron  transport
chains, since the toxin can act as electron carriers. Although
the mechanism behind the hormesis effect is unknown, and its
existence even disputed, some believe that repair mechanisms
activated due to the low levels of toxins also repair other
damage that would have otherwise gone undetected [24,25].
In  summary,  results  from  the  ScanTox™  system  and
confocal microscopy suggest that mitochondrial integrity and
morphology are associated with optical quality of the lens.
Further work into the effects of mitochondrial breakdown and
cytoskeletal  integrity  would  confirm  the  role  of  the
cytoskeleton in optic function and cataract formation, which
has been suggested for years [26].
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